文献速递皮肤肿瘤

模拟日光与常规光动力疗法治疗表浅基底细胞癌的随机对照试验

Simulated daylight vs. conventional PDT for clinical superficial BCC: A randomized controlled trial.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2025-02-18

单中心非劣效性随机对照试验纳入78例患者共193个临床诊断的表浅基底细胞癌,比较模拟日光光动力疗法(SDL-PDT)与常规光动力疗法(C-PDT)的疗效与疼痛。1年清除率SDL-PDT为62.4%,C-PDT为91.8%(p<0.001),非劣效性不成立;SDL-PDT疼痛显著更低,多数患者偏好SDL-PDT。

要点

  • SDL-PDT的1年清除率显著低于C-PDT,不支持作为sBCC首选治疗。
  • C-PDT光照时疼痛更高,SDL-PDT疼痛评分极低。
  • 多数患者治疗后即刻偏好SDL-PDT。

核心结论

  • SDL-PDT疗效劣于C-PDT,但疼痛更轻,因清除率较低不推荐作为sBCC的主要治疗选择。

研究设计与样本

  • 单中心、非劣效性、随机对照试验,纳入成人表浅基底细胞癌患者,病灶随机接受两次SDL-PDT或C-PDT(氨基酮戊酸为光敏剂)。
  • 共78例参与者、193个sBCC病灶;47.2%位于躯干,64.2%仅通过皮肤镜检查诊断。

主要发现

  • 1年清除率:SDL-PDT组62.4%,C-PDT组91.8%(p<0.001),非劣效性不成立。
  • 光照疼痛(NRS 0-10):C-PDT第1次平均3.5、第2次平均3.7;SDL-PDT两次均平均0.1(p<0.001)。
  • 治疗即刻87.5%的受访者偏好SDL-PDT。

关键数值与推荐

  • 非劣效性检验未通过:SDL-PDT 1年清除率62.4% vs C-PDT 91.8%(p<0.001)。
  • 疼痛评分:C-PDT平均NRS 3.5-3.7,SDL-PDT平均0.1(p<0.001)。

临床怎么用

  • 临床决策需权衡疗效与疼痛:SDL-PDT疼痛低但清除率不足,不宜作为sBCC首选。
  • 对疼痛敏感或无法耐受C-PDT者,可个体化讨论SDL-PDT的较低清除率风险。

局限性

  • 单中心研究,样本量有限(78例患者、193个病灶)。
  • 多数病灶仅基于皮肤镜诊断,未行病理确诊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Photodynamic therapy (PDT) is a recognized treatment for superficial basal cell carcinoma (sBCC). Conventional PDT (C-PDT) has a relatively high clearance rate but is time-consuming and painful. Simulated daylight PDT (SDL-PDT) has the potential advantage of causing less pain, but its effectiveness has not been investigated thoroughly. OBJECTIVES: To determine whether SDL-PDT is non-inferior to C-PDT in the treatment of clinically diagnosed sBCC and to assess adverse events during treatment and patient preferences. METHODS: In this single-centre, non-inferiority, randomized controlled trial, adult patients with sBCCs of any size and located on anatomical sites suitable for PDT were recruited. Lesions were randomized to two sessions of either SDL-PDT or C-PDT using aminolevulinic acid as the photosensitizer. Patient-perceived pain was measured using a numeric rating scale (NRS) ranging from 0 to 10. Self-report forms were used to measure patient preferences. Patients were evaluated after 3 months to assess early treatment failure and after 1 year to determine overall clearance rates. RESULTS: In total, 78 participants with 193 sBCCs were treated. Most lesions (47.2%) were located on the trunk and were diagnosed solely through dermoscopic evaluation (64.2%). After 1 year, the clearance rate was 62.4% for SDL-PDT and 91.8% for C-PDT (p < 0.001) disproving non-inferiority. Illumination was reported to be more painful during C-PDT (mean NRS score of 3.5 at session 1 and 3.7 at session 2) compared with SDL-PDT (mean NRS score of 0.1 at both sessions) (p < 0.001). Immediately after treatment, 87.5% of respondents expressed a preference for SDL-PDT. CONCLUSIONS: SDL-PDT is less effective than C-PDT but is also less painful. Due to the lower clearance rate, this study does not support SDL-PDT as a primary treatment option for sBCC. The randomized controlled trial was registered at http://www.researchweb.org/ (project 264721).

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Sjöholm A, Backman E, Modin M, et al. Simulated daylight vs. conventional PDT for clinical superficial BCC: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2025. PMID: 39963779. doi:10.1111/jdv.20602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。